Performance and safety profile of regadenoson myocardial perfusion imaging: first experience in Greece.
CONCLUSION: Our findings support previously published data indicating the optimal safety profile of regadenoson MPI, even in the group of patients suffering from chronic obstructive pulmonary disease.
PMID: 29177261 [PubMed - as supplied by publisher]
Source: Hellenic Journal of Nuclear Medicine - Category: Nuclear Medicine Tags: Hell J Nucl Med Source Type: research
More News: Arrhythmia | Chronic Obstructive Pulmonary | Chronic Pain | Electrocardiogram | Greece Health | Headache | Heartburn | Lexiscan | Migraine | Nuclear Medicine | Pain | Perfusion | Study